Reporting its financial results and continued progress across short-acting psychedelics portfolio
Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.
All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2023.
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).